Caricamento...
抗CD19 CAR-T细胞治疗难治复发B细胞肿瘤10例临床分析
OBJECTIVE: To investigate the outcomes of anti-CD19 CAR-T cell for relapsed and refractory B cell malignancies. METHODS: Ten patients with relapsed and refractory B cell acute lymphocytic leukemia (B-ALL) and non-Hodgkin's lymphoma (NHL), diagnosed in the Department of Hematology of Peking Univ...
Salvato in:
| Pubblicato in: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Editorial office of Chinese Journal of Hematology
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342922/ https://ncbi.nlm.nih.gov/pubmed/30032559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.06.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|